Top 4 Large-Cap Stocks In The Biotechnology Industry With The Highest Operating Margin (GILD, AMGN, BIIB, CELG)
Below are the top large-cap biotechnology stocks on the NYSE and the NASDAQ in terms of operating margin.
The trailing-twelve-month operating margin at Gilead Sciences Inc (NASDAQ: GILD) is 52.04%. GILD's PEG ratio is 0.70.
The trailing-twelve-month operating margin at Amgen Inc (NASDAQ: AMGN) is 37.62%. AMGN's revenue for the same period is $15.05 billion.
The trailing-twelve-month operating margin at Biogen Idec Inc (NASDAQ: BIIB) is 33.41%. BIIB's ROE for the same period is 15.35%.
The trailing-twelve-month operating margin at Celgene Corporation (NASDAQ: CELG) is 32.20%. CELG's PEG ratio is 0.65.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Biotechnology Industry Highest Operating Margin Large-CapMarkets Trading Ideas